Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Chronic Hepatitis C Virus”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Not applicableStudy completedNCT03197155
What this trial is testing

Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence

Who this might be right for
Hepatocellular CarcinomaHepatitis CDirect Acting Antivirals
Hospices Civils de Lyon 68
Post-approval studies (Phase 4)Study completedNCT04695769
What this trial is testing

Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders

Who this might be right for
Chronic Hepatitis C
Helwan University 281
Testing effectiveness (Phase 2)Study completedNCT01121731
What this trial is testing

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus InfectionGenotype 1Treatment-Experienced Patients+1 more
Digna Biotech S.L. 70
Testing effectiveness (Phase 2)Study completedNCT01559844
What this trial is testing

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Who this might be right for
Hepatitis CHepatocellular Carcinoma
Gilead Sciences 61
Post-approval studies (Phase 4)Study completedNCT00087633
What this trial is testing

PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 115
Not applicableApproved For MarketingNCT01779518
What this trial is testing

Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C

Who this might be right for
Post-transplant Hepatitis C
Gilead Sciences
Large-scale testing (Phase 3)UnknownNCT03551444
What this trial is testing

Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial

Who this might be right for
Hepatocellular CarcinomaHepatitis C, Chronic
Ain Shams University 80
Post-approval studies (Phase 4)Study completedNCT01134952
What this trial is testing

Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
London Health Sciences Centre 11
Not applicableEnded earlyNCT00867243
What this trial is testing

Prediction of Hepatitis C Recurrence in Liver Transplant Recipients

Who this might be right for
Complication of Transplanted LiverHepatitis C, Chronic
Northwestern University 24
Large-scale testing (Phase 3)Study completedNCT00378599
What this trial is testing

Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)

Who this might be right for
Liver TransplantationHepatitis C, ChronicLiver Cirrhosis
Merck Sharp & Dohme LLC 125
Post-approval studies (Phase 4)Study completedNCT00993122
What this trial is testing

Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients

Who this might be right for
Hepatitis C
University of Roma La Sapienza 100
Not applicableStudy completedNCT03127358
What this trial is testing

Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs

Who this might be right for
Hepatitis CMedication Adherence
Albert Einstein College of Medicine 11
Not applicableUnknownNCT04732832
What this trial is testing

HCV Reinfection in HD Patients Achieving SVR

Who this might be right for
Hepatitis C Virus InfectionHepatitis C Virus Infection, Response to Therapy ofHemodialysis Complication
National Taiwan University Hospital 350
Early research (Phase 1)Study completedNCT00519792
What this trial is testing

Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment

Who this might be right for
Chronic Hepatitis C
Intarcia Therapeutics 60
Not applicableStudy completedNCT03343925
What this trial is testing

Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based Settings

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 140
Testing effectiveness (Phase 2)Study completedNCT01687270
What this trial is testing

Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant

Who this might be right for
Recurrent Chronic Hepatitis C VirusPost Liver Transplant
Gilead Sciences 40
Not applicableStudy completedNCT02824640
What this trial is testing

Patient-Centered Models of HCV Care for People Who Inject Drugs

Who this might be right for
Hepatitis CMedication Adherence
Prisma Health-Upstate 755
Testing effectiveness (Phase 2)Study completedNCT00695019
What this trial is testing

Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. 169
Post-approval studies (Phase 4)Ended earlyNCT00641654
What this trial is testing

Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin

Who this might be right for
Chronic Hepatitis C
Göteborg University 75
Not applicableNo Longer AvailableNCT02161939
What this trial is testing

Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb
Load More Results